OSTN and renal carcinoma: Indeed, low levels of musclin have been observed in atrophying skeletal myotubes and in plasma and muscles of cancer-bearing mice, while the electroporation of musclin-encoding plasmids nullified muscle atrophy manifestations in renal cancer-bearing mice [6,70].